AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

MSN Sita-M 50mg/1000mg Tablet

Prescription Icon
Prescription Required

Marketer

MSN Laboratories

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview MSN Sita-M 50mg/1000mg Tablet

Sita-M 50mg/1000mg tablets combine two medications to effectively manage elevated blood glucose in individuals with type 2 diabetes. This dual action helps mitigate serious diabetic complications like renal impairment and vision loss, potentially lowering the risk of cardiovascular events. Sita-M may be used as monotherapy or in conjunction with other antidiabetic agents. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is tailored to individual needs, considering existing health conditions, blood sugar readings, and concurrent medications. Consuming the tablet with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefit; discontinuation should only occur under medical supervision. Adherence to the prescribed diet and exercise plan is crucial for overall diabetes control. Commonly reported side effects include nausea, vomiting, diarrhea, stomach upset, headache, and pharyngitis. Hypoglycemia is a potential risk, particularly when used with insulin or sulfonylureas; proper recognition and management strategies are essential. This medication isn't appropriate for all patients. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or heart conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating women require medical consultation before initiating therapy. Drug interactions are possible; disclose all other medications to ensure treatment safety. Alcohol should be minimized due to its hypoglycemic effect. Your physician will monitor kidney function and blood glucose levels throughout the treatment period.

Primary Ingredients of MSN Sita-M 50mg/1000mg Tablet

The provided text is "undefined," which offers no content to rephrase. Therefore, no rewritten text can be provided.

Uses of MSN Sita-M 50mg/1000mg Tablet

Managing type 2 diabetes

Major Benefits of MSN Sita-M 50mg/1000mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or fracturing it. The Sita-M 50mg/1000mg tablet should be administered with food.

Common Side effects of MSN Sita-M 50mg/1000mg Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use MSN Sita-M 50mg/1000mg Tablet:

Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. The Sita-M 50mg/1000mg tablet should be administered with a meal.

How MSN Sita-M 50mg/1000mg Tablet works:

Sita-M 50mg/1000mg tablets contain sitagliptin and metformin, working synergistically to manage blood glucose. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and lessens hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol ingestion and MSN Sita-M 50mg/1000mg tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Sita-M 50mg/1000mg tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The medication Sita-M 50mg/1000mg Tablets is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar fluctuations.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Sita-M 50mg/1000mg tablets. Dosage modification may be necessary; physician consultation is recommended. Sita-M 50mg/1000mg tablets are contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.

LiverLiverUNSAFE

Use of Sita-M 50mg/1000mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Seek medical advice before use.

What if you forget to take MSN Sita-M 50mg/1000mg Tablet :

Should you forget to take a scheduled dose of your MSN Sita-M 50mg/1000mg Tablet, administer it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take more than the prescribed dosage.

Facts to Know About MSN Sita-M 50mg/1000mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on MSN Sita-M 50mg/1000mg Tablet

MSN Sita-M 50mg/1000mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of MSN Sita-M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
MSN Sita-M 50mg/1000mg Tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Patients with known allergies to MSN Sita-M 50mg/1000mg Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining alcohol and MSN Sita-M 50mg/1000mg tablets is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; keep it out of reach of children, pets, and others.
Metformin, a component of MSN Sita-M 50mg/1000mg Tablet, can rarely cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA). This risk is heightened in individuals with kidney disease, the elderly, and heavy alcohol users. Symptoms may include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
MSN Sita-M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
MSN Sita-M 50mg/1000mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are possible. Prolonged use may also result in vitamin B12 deficiency.
Patients allergic to MSN Sita-M 50mg/1000mg Tablet components or excipients should not use it. This medication is contraindicated in individuals with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining alcohol and MSN Sita-M 50mg/1000mg tablets is unsafe and may raise your risk of lactic acidosis.
Lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis), is a potential side effect of MSN Sita-M 50mg/1000mg tablets. This occurs due to elevated blood lactic acid levels. Because it's rare, metformin is avoided in patients with kidney disease, the elderly, and heavy alcohol users. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita-M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
MSN Sita-M 50mg/1000mg tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
MSN Sita-M 50mg/1000mg tablets may cause common side effects including hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use can result in vitamin B12 deficiency.
Patients allergic to MSN Sita-M 50mg/1000mg Tablet components or excipients, or with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis, should not use this medication.
Combining alcohol and MSN Sita-M 50mg/1000mg tablets is unsafe and may heighten the risk of lactic acidosis.
Metformin, a component of MSN Sita-M 50mg/1000mg Tablet, can rarely cause lactic acidosis (MALA), a serious medical emergency characterized by excessive blood lactic acid. This risk is heightened in individuals with kidney disease, the elderly, and heavy alcohol consumers. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin + Metformin and seek immediate medical attention.
Prolonged use of MSN Sita-M 50mg/1000mg tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, neurological issues (including numbness, tingling in extremities, weakness, and ataxia), and urinary problems. To mitigate these risks, annual supplemental vitamin B12 intake is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it remains inaccessible to children, pets, and others.
MSN Sita-M 50mg/1000mg Ta...
118